NCT00664066View on ClinicalTrials.gov

DELFT (Dynepo Evaluation of Long-Term Follow-Up Treatment)

TerminatedOBSERVATIONAL
Enrollment

3

Participants

Timeline

Start Date

April 25, 2008

Primary Completion Date

July 30, 2008

Study Completion Date

July 30, 2008

Conditions
AnemiaKidney DiseasesRenal Failure, ChronicKidney Failure, Chronic
Interventions
DRUG

DYNEPO (epoetin delta)

dose, dose frequency, route of administration (iv or sc) and duration will be determined by the investigator according to their normal prescribing habits, as this is an observational study

Trial Locations (2)

78054

Nephrologische Zentrum Villingen-Schwenningen, Villingen-Schwenningen

Unknown

Hanse-Klinikum Stralsund, Stralsund

Sponsors

Lead Sponsor

Shire
All Listed Sponsors
lead

Shire

INDUSTRY

NCT00664066 - DELFT (Dynepo Evaluation of Long-Term Follow-Up Treatment) | Biotech Hunter | Biotech Hunter